AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
203.87
+2.37 (1.18%)
At close: Oct 31, 2024, 4:00 PM
203.16
-0.71 (-0.35%)
After-hours: Oct 31, 2024, 6:25 PM EDT
AbbVie Employees
AbbVie had 50,000 employees as of January 31, 2024. The number of employees did not change compared to the previous year.
Employees
50,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,110,660
Profits / Employee
$101,580
Market Cap
360.10B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jan 31, 2024 | 50,000 | 0 | - |
Jan 31, 2023 | 50,000 | 0 | - |
Jan 31, 2022 | 50,000 | 3,000 | 6.38% |
Jan 31, 2021 | 47,000 | 17,000 | 56.67% |
Jan 31, 2020 | 30,000 | 0 | - |
Jan 31, 2019 | 30,000 | 1,000 | 3.45% |
Jan 31, 2018 | 29,000 | -1,000 | -3.33% |
Jan 31, 2017 | 30,000 | 2,000 | 7.14% |
Jan 31, 2016 | 28,000 | 2,000 | 7.69% |
Jan 31, 2015 | 26,000 | 1,000 | 4.00% |
Jan 31, 2014 | 25,000 | 3,500 | 16.28% |
Jan 31, 2013 | 21,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ABBV News
- 10 hours ago - AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics - GlobeNewsWire
- 10 hours ago - AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics - PRNewsWire
- 23 hours ago - AbbVie: 3 Positives From The Earnings Report - Seeking Alpha
- 1 day ago - AbbVie Inc. (ABBV) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 1 day ago - AbbVie Tops Q3 Expectations As Skyrizi, Rinvoq Drive Growth - Benzinga
- 1 day ago - AbbVie Stock Rises After Earnings Beat, Dividend Hike - Barrons
- 1 day ago - AbbVie raises 2024 profit forecast on strong sales of key drugs Skyrizi, Rinvoq - Reuters
- 1 day ago - AbbVie Reports Third-Quarter 2024 Financial Results - PRNewsWire